Biochemical markers in prostatic cancer.
The status of the biochemical markers explored for use in patients with carcinoma of the prostate is reviewed. No unique marker has been identified. However, a variety of substances, primarily enzymes and specific proteins, found in the serum, urine, and prostatic fluid, have been evaluated. Their main value remains in the staging of disease and the monitoring of response to therapy.
D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D000596:Amino Acids / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D001826:Body Fluids / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000378:metabolism*; D002784:Cholesterol / Q000032:analysis; D003402:Creatine Kinase / Q000032:analysis; D005353:Fibronectins / Q000032:analysis; D005956:Glucose-6-Phosphate Isomerase / Q000032:analysis; D006801:Humans; D006909:Hydroxyproline / Q000032:analysis; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D009961:Orosomucoid / Q000032:analysis; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000378:metabolism*; D012260:Ribonucleases / Q000032:analysis; D013095:Spermidine / Q000032:analysis; D000509:alpha-Fetoproteins / Q000032:analysis
D000596:Amino Acids; D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D005353:Fibronectins; D007527:Isoenzymes; D009961:Orosomucoid; D000509:alpha-Fetoproteins; D002784:Cholesterol; D007770:L-Lactate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D003402:Creatine Kinase; D012260:Ribonucleases; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen; D005956:Glucose-6-Phosphate Isomerase; D006909:Hydroxyproline; D013095:Spermidine